Insulin glargine and lixisenatide Subcutaneous and Lixtraxen Injection
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Lixtraxen Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: epinephrine / lidocaine
Brand name: D-Care 100X, Lignospan Forte, Lignospan Standard, Xylocaine MPF With Epinephrine, Xylocaine With Epinephrine
Synonyms: Lidocaine and Epinephrine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-LMD
- Insulin glargine and lixisenatide Subcutaneous-LMD Injection
- Insulin glargine and lixisenatide Subcutaneous-LMX 4 Topical application
- Insulin glargine and lixisenatide Subcutaneous-LMX 5
- Insulin glargine and lixisenatide Subcutaneous-LMX 5 Topical application
- Insulin glargine and lixisenatide Subcutaneous-Lo Loestrin Fe
- Lixtraxen Injection-Insulin glargine, recombinant Subcutaneous
- Lixtraxen Injection-Insulin glulisine
- Lixtraxen Injection-Insulin Glulisine (Cartridges and Pens)
- Lixtraxen Injection-Insulin Glulisine (Vials)
- Lixtraxen Injection-Insulin glulisine Subcutaneous
- Lixtraxen Injection-Insulin human inhaled Inhalation